Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News

April 2004

Corin Group PLC Increases Sales by 39% by Targeting Baby Boomer Patient Population BY JOHN CHOPACK, APRIL 19, 2004

While it is widely accepted that the baby boomer population will have a significant impact on the overall orthopedic industry, we believe that the Corin Group, located in the UK, has developed a unique product offering to address this younger,... more

Stryker Corp & DePuy Report 1Q:04 Earnings and Provide Insight into Strength of Large Joint Reconstructive Market BY JOHN CHOPACK, APRIL 19, 2004

DePuy and Stryker Corp. both reported their 1Q:04 earnings during the last week of trading activities. This provided some insight into both the strength of the Large Joint Orthopedic market and how the additional orthopedic companies will report during the... more

Fat Derived Stem Cells Reach Important Milestones to Commercialization for bone, cartilage and muscle repair BY ROBIN R. YOUNG CFA, APRIL 19, 2004

In two separate studies, stem cells derived from the patient's own fat tissue, otherwise known as adipose derived stem cells, were shown to adapt and grow into either bone tissue or heart muscle tissue, without requiring any external growth factors... more

Macropore Posts 140% Revenue Jump on Sales of Resorbable Polymers for Spine, Trauma and Carniomaxillofacial; Losses Continue, Though Reduced BY ROBIN R. YOUNG CFA, APRIL 19, 2004

Macropore, the San Diego based biomaterials company whose stock trades on the Frankfurt exchange (go figure), posted exceptional revenue growth for the December quarter. (They're a little behind on their announcements. March quarter numbers due in June?) Sales for the... more

Medtronic's InFuse® cutting into DePuy Spine's Sales BY ROBIN R. YOUNG CFA, APRIL 19, 2004

For the quarter ended this past March, JNJ's DePuy spine division reported that sales growth rates for that division were slowing. For 2004, we forecast, sales of spinal implants industry-wide will rise 24% from last year's $2.9 billion to $3.6... more

FDA Approves Second Growth Factor for the Spine BY ROBIN R. YOUNG CFA, APRIL 12, 2004

With InFuse® (BMP 2) selling at a rate of $1 million per day for Medtronic's Sofamor Danek subsidiary, the news that Stryker Corporation has received approval to sell OP-1 (BMP 7) for spinal indications is significant news. Three years ago,... more

FDA approves use of polymethylmethacrylate (PMMA) in spine - specifically for Vertebral Compression Fractures BY ROBIN R. YOUNG CFA, APRIL 5, 2004

Kyphon announced this morning that its application to receive FDA approval for its PMMA bone cement product, KyphX® HV-R™ Bone Cement, has been approved. This will be the first approved PMMA bone cement for use in the spine. PMMA has... more


The IPO market for orthopedic and related companies is clearly heating up this year. Witness the recent offerings from NuVasive and dj Orthopedics. Now St. Paul, MN based orthopedic rehabilitation company EMPI, Inc. has just filed its Registration Statement with... more

John Kerry: Presidential Candidate and Sports Medicine Patient BY JOHN MCCORMICK, APRIL 5, 2004

Presidential contender John Kerry is probably wishing he had a war story to tell about his torn subscapularis tendon, but alas, a mundane fall on a stopping bus is all he had to report. What is not widely discussed is... more

Kyphon Sues Disc-O-Tech alleging Patent Infringement and a NEW vertebral compression fracture balloon patent is issued by U.S. Patent office - but not to Kyphon You'll never guess who's got it BY ROBIN R. YOUNG CFA, APRIL 5, 2004

It was middle of the afternoon at Kyphon's headquarters, but after 6pm Eastern Standard Time when Kyphon issued an announcement that it was suing start-up company Disc-O-Tech in both U.S. District Court and at the International Trade Commission for patent... more

First Quarter Preview - Sales +15%, Currency Affect Strong as Dollar Declined 3-4% against Euro and Yen BY ROBIN R. YOUNG CFA, APRIL 5, 2004

Orthopedic revenues for the quarter ended March 31, 2004 will, we expect, rise 15% to $5.4 billion. Considering that revenues for last year's initial quarter rose 15% to a record breaking $4.7 billion, this is very impressive. In raw dollars,... more

Complete Archive